Bank of America
TENX icon

Bank of America’s Tenax Therapeutics TENX Stock Holding History

Bank of America’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-11
Closed -$1.38M – 7952
2014
Q3 		$1.38M Sell
11
-9
-45% -$1.16M ﹤0.01% 3719
2014
Q2 		$2.65M Buy
+20
New +$3.08M ﹤0.01% 3113

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of America's TENX Position: Q1 2026 in Review

Bank of America increased its Tenax Therapeutics (TENX) stake by 391% in Q1 2026, buying an estimated $200K and bringing the position to 18,569 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #5160.

Bank of America first reported a position in TENX in Q2 2014 and has held it in 10 quarters since. The position peaked at $2.94M in Q2 2014. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Bank of America held 18,569 shares of Tenax Therapeutics worth $297K as of Q1 2026.
  • Bank of America bought 14,789 Tenax Therapeutics shares in Q1 2026, an estimated $200K.
  • Tenax Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5160 holding.
  • Bank of America first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 10 quarters since.
  • Bank of America's Tenax Therapeutics position peaked at $2.94M in Q2 2014.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.